Alexandria Real Estate Equities IncNYSE:ARE
- LAST PRICE116.6200
- TODAY'S CHANGE (%)0.8100 (0.6994%)
- Bid / Lots116.6200/ 10
- Ask / Lots116.6600/ 1
- Open / Previous Close116.2500 / 115.8100
- Day Range
- 52 Week Range
- Volume61,532
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ARE |
|---|---|---|
| 09:32 ET | 5604 | 116.62 |
| 09:34 ET | 448 | 116.24 |
| 09:36 ET | 520 | 115.95 |
| 09:38 ET | 1764 | 116.05 |
| 09:39 ET | 700 | 116.34 |
| 09:41 ET | 193 | 116.69 |
| 09:43 ET | 100 | 116.555 |
| 09:45 ET | 100 | 116.34 |
| 09:50 ET | 100 | 116.84 |
| 09:52 ET | 350 | 116.66 |
| 09:54 ET | 582 | 116.76 |
| 09:56 ET | 100 | 116.82 |
| 09:59 ET | 625 | 116.825 |
| 10:01 ET | 2302 | 116.755 |
| 10:03 ET | 732 | 116.77 |
| 10:08 ET | 500 | 116.87 |
| 10:10 ET | 100 | 116.9 |
| 10:12 ET | 466 | 116.94 |
| 10:14 ET | 700 | 116.89 |
| 10:15 ET | 200 | 116.805 |
| 10:19 ET | 100 | 116.7963 |
| 10:24 ET | 146 | 116.9 |
| 10:26 ET | 100 | 116.9 |
| 10:30 ET | 783 | 116.8926 |
| 10:32 ET | 625 | 116.99 |
| 10:33 ET | 100 | 117.14 |
| 10:35 ET | 100 | 117.1 |
| 10:37 ET | 1611 | 117.09 |
| 10:39 ET | 200 | 117.15 |
| 10:42 ET | 100 | 117.18 |
| 10:44 ET | 602 | 117.06 |
| 10:46 ET | 612 | 116.945 |
| 10:48 ET | 100 | 116.945 |
| 10:50 ET | 212 | 116.89 |
| 10:51 ET | 100 | 116.925 |
| 10:53 ET | 200 | 116.845 |
| 10:55 ET | 668 | 116.9 |
| 10:57 ET | 400 | 116.91 |
| 11:00 ET | 783 | 116.952 |
| 11:02 ET | 100 | 116.985 |
| 11:04 ET | 5628 | 116.845 |
| 11:06 ET | 2700 | 116.78 |
| 11:08 ET | 400 | 116.71 |
| 11:09 ET | 400 | 116.765 |
| 11:13 ET | 225 | 116.5702 |
| 11:15 ET | 171 | 116.62 |
| 11:20 ET | 6301 | 116.55 |
| 11:26 ET | 100 | 116.62 |
Jun 28, 2024
Jun 25, 2024
Alexandria Real Estate Equities, Inc. Announces Long-Term 127,382 RSF Lease With Top 20 Pharmaceutical Company and Longstanding Credit Tenant for New R&D Life Science Center at the SD Tech by Alexandria Mega Campus in San Diego, from 8:30AM ET on Tuesday Jun 25, 2024 by Dow Jones
8:30AM ET on Tuesday Jun 25, 2024 by Dow Jones
Jun 3, 2024
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.30 per Common Share for 2Q24, an Increase of 3 Cents Over 1Q24, and an Aggregate of $5.08 per Common Share for the 12 Months Ending June 30, 2024, an Increase of 24 Cents, or 5 Percent, Over the 12 Months Ended June 30, 2023, from 8:30AM ET on Monday Jun 03, 2024 by Dow Jones
8:30AM ET on Monday Jun 03, 2024 by Dow JonesPress Release: Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.30 per Common Share for 2Q24, an Increase of 3 Cents Over 1Q24, and an Aggregate of $5.08 per Common Share for the 12 Months Ending June 30, 2024, an Increase of 24 Cents, or 5 Percent, Over the 12 Months Ended June 30, 2023, from 8:30AM ET on Monday Jun 03, 2024 by Dow Jones
8:30AM ET on Monday Jun 03, 2024 by Dow Jones
Industry Peers
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alexandria Real Estate Equities Inc | 20.3B | 108.8x | -31.25% |
SBA Communications Corp | 20.4B | 36.8x | +66.94% |
Equity Residential | 25.8B | 28.3x | +4.42% |
Invitation Homes Inc | 21.9B | 40.8x | --- |
Sun Communities Inc | 14.8B | -69.5x | --- |
AvalonBay Communities Inc | 29.1B | 30.4x | -1.37% |
Company Information
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Contact Information
- Headquarters
- 26 North Euclid AvenuePASADENA, CA, United States 91101
- Phone
- 626-578-0777
- Fax
- 626-578-0896
Executives
- Founder, Executive Chairman of the Board
- Joel Marcus
- Chief Executive Officer, Chief Investment Officer
- Peter Moglia
- Chief Financial Officer, Treasurer
- Marc Binda
- Co-President and Regional Market Director, Greater Boston
- Hunter Kass
- Co-President and Regional Market Director, San Diego
- Daniel Ryan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Dividend Yield | 4.46% |
Annual Dividend Rate | 5.2000 USD |
Ex-Dividend Date | 06-28-24 |
Pay Date | 07-15-24 |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | 108.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
